Head and Neck Cancer Survivorship Symposium Set for July 2020

The nation’s leading head and neck cancer organizations are joining in partnership to host the Head and Neck Cancer Survivorship Symposium July 18, 2020, from 10am – 4pm in Chicago, IL.

Smash Cancer Tennis Tournament Celebrates its 10th Anniversary

May 17-19, 2019 marked the 10th annual Smash Cancer Tennis Tournament in Wilmington, NC. HNCA Executive Director, Amanda Hollinger, attended the tournament and sat down for a conversation with tournament organizer Christine Tatum.

Find Inspiration and Hope Through the Power of Storytelling with the Newly Launched With Love, Me Program

There’s great power in sharing stories, and when it comes to facing cancer, patients and caregivers have found hearing from others affected by cancer may help.

Join the Head and Neck Cancer Alliance’s Free Online Support Community on Inspire

The Head and Neck Cancer Alliance (HNCA) is proud to support a free online community on Inspire for individuals, and their loved ones, who are facing oral, head and neck cancers.

Clinical Trial Opportunity for Head & Neck Cancer with FGFR 1, 2, or 3 Fusions

The FUZE Clinical Trial is evaluating an oral investigational medication, called Debio 1347, that may block cancer cell growth. You may qualify if you have an advanced head or neck cancer with a specific genetic alteration, called a fusion of FGFR 1, 2, or 3 receptor. If your head or neck cancer has progressed after treatment, ask your doctor about a new clinical trial that focuses on this specific genetic alteration. Every tumor has a genetic makeup. Learn more at FuzeTrial.com.

Learn about other trials that are now recruiting.